Study on anticancer drugs approved by the FDA from 2014 to 2023
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | Thesis |
| Idioma: | English |
| Publicado em: |
Brac University
2024
|
| Assuntos: | |
| Acesso em linha: | http://hdl.handle.net/10361/23989 |
| id |
10361-23989 |
|---|---|
| record_format |
dspace |
| spelling |
10361-239892024-09-05T21:00:27Z Study on anticancer drugs approved by the FDA from 2014 to 2023 Rattry, Faria Rahman Asaduzzaman, Muhammad School of Pharmacy, Brac University FDA-Food and Drug Administration Radiation therapy Anticancer drugs Cancer--Treatment. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. Cataloged from the PDF version of thesis. Includes bibliographical references (pages 33-34). Cancer is a condition of uncontrolled growth and spread of cells in the body. Cancer is the second leading cause of death in the world. Cancer is basically classified according to the resemblance of tumor cell to a specific type of cell, which is believed to be the origin of the tumor. Most common type of cancers are lung cancer, liver cancer, breast cancer, colorectal cancer, prostate cancer, thyroid cancer, leukemia, lymphoma, melanoma, bladder cancer etc. Various types of cancer treatment are available like chemotherapeutic drugs, radiation therapy, surgery etc. One of the most used cancer treatments is chemotherapy. But it developed chemotherapy resistance. Particularly in progressive disease, resistance to chemotherapy is frequently observed. Thus, researchers are now focusing on targeted therapies based on the tumor-specific factors. In this research, chemotherapeutic drug is the main focus among the different types of cancer treatment. A detailed analysis is done by compiling all the approved chemotherapeutic drugs by the FDA from 2014 to 2023. This study highlights the approved anticancer drugs with their indication and dosage forms. Faria Rahman Rattry B. Pharmacy 2024-09-05T09:02:50Z 2024-09-05T09:02:50Z ©2024 2024-04 Thesis ID 20146013 http://hdl.handle.net/10361/23989 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 34 pages. application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
FDA-Food and Drug Administration Radiation therapy Anticancer drugs Cancer--Treatment. |
| spellingShingle |
FDA-Food and Drug Administration Radiation therapy Anticancer drugs Cancer--Treatment. Rattry, Faria Rahman Study on anticancer drugs approved by the FDA from 2014 to 2023 |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024. |
| author2 |
Asaduzzaman, Muhammad |
| author_facet |
Asaduzzaman, Muhammad Rattry, Faria Rahman |
| format |
Thesis |
| author |
Rattry, Faria Rahman |
| author_sort |
Rattry, Faria Rahman |
| title |
Study on anticancer drugs approved by the FDA from 2014 to 2023 |
| title_short |
Study on anticancer drugs approved by the FDA from 2014 to 2023 |
| title_full |
Study on anticancer drugs approved by the FDA from 2014 to 2023 |
| title_fullStr |
Study on anticancer drugs approved by the FDA from 2014 to 2023 |
| title_full_unstemmed |
Study on anticancer drugs approved by the FDA from 2014 to 2023 |
| title_sort |
study on anticancer drugs approved by the fda from 2014 to 2023 |
| publisher |
Brac University |
| publishDate |
2024 |
| url |
http://hdl.handle.net/10361/23989 |
| work_keys_str_mv |
AT rattryfariarahman studyonanticancerdrugsapprovedbythefdafrom2014to2023 |
| _version_ |
1814306894338064384 |